侨雄国际(00381.HK)终止就果汁供应协议及饮用酒供应协议发行股份
格隆汇8月23日丨侨雄国际(00381.HK)公布,于2019年6月3日,公司全资附属福建侨兴酒业作为买方分别与供应商甲沈阳杰欧森贸易及供应商乙江西安发达酒业订立果汁供应协议及饮用酒供应协议,内容分别有关供应果汁和供应饮用酒予买方。其中果汁供应协议总合约金额为人民币8064万元,饮用酒供应协议总合约金额人民币9126万元。
果汁供应协议及饮用酒供应协议所涉根据一般授权发行及配发新股份的前提条件未获达成。因此,董事会已同意终止根据一般授权发行及配发新股份,公司并无或将不会就果汁供应协议及饮用酒供应协议根据一般授权发行股份。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.